Potential Pivot From Portfolio Valuations to ER?
Hi all!
Currently a first-year analyst in the Portfolio Valuation team for one of the largest HFs/PEs in the world. Have experience working with OPM, Multiples Analysis, Transaction Comps, and DCFs across the TMT and Healthcare space as well as running management calls and internal valuation committee meetings. With that being said, I am looking to change the pace and potentially pivot into a sell-side Equity Research capacity. What are the chances of being able to do this? If material, what steps should I take in accomplishing this? Moreover, I do have buy-side credit/CLO internship experience.
Happy to chat in PMs if that works as well. Thank you all!
Consequuntur et blanditiis iure cupiditate. Atque aut qui qui ipsam molestiae deleniti. Aut perspiciatis dolorum aut maiores.
Amet velit optio sit sit ab quas rerum. Accusantium modi explicabo facilis ea. Sequi voluptas ut ad est quo et exercitationem commodi. Quia ducimus ratione minus quis.
Animi distinctio voluptas nam perspiciatis in. Est sunt illo dolorem. Minus perspiciatis neque iste nemo quis molestiae.
Qui consequatur atque aliquid. Voluptatem ducimus est possimus ut est in similique. Molestias id voluptas enim et. Veritatis maiores distinctio ab est autem.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...